← Back to headlines
AI Aids Pharmaceutical Companies Amid Patent Crisis
Artificial intelligence is being leveraged by pharmaceutical companies to reduce the time and cost of drug development by up to 35%, offering a solution to the ongoing patent crisis.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
6h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
16h ago